Alliance Wealth Advisors (Utah)’s Amgen AMGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$294K Sell
813
-23
-3% -$7.87K 0.06% 191
2026
Q1
$294K Buy
836
+38
+5% +$13.5K 0.06% 190
2025
Q4
$261K Buy
798
+54
+7% +$17.1K 0.06% 223
2025
Q3
$210K Buy
+744
New +$216K 0.05% 263
2023
Q1
Sell
-1,558
Closed -$409K 222
2022
Q4
$409K Buy
+1,558
New +$418K 0.18% 122

Other funds holding AMGN

Alliance Wealth Advisors (Utah)'s AMGN Position: Q2 2026 in Review

Alliance Wealth Advisors (Utah) reduced its Amgen (AMGN) stake by 2.8% in Q2 2026, selling an estimated $7.87K and leaving 813 shares worth $294K. The position accounts for 0.06% of the portfolio, ranked #191.

Alliance Wealth Advisors (Utah) first reported a position in AMGN in Q4 2022 and has held it in 5 quarters since. The position peaked at $409K in Q4 2022. 1,447 funds tracked by Wall St. Rank hold AMGN as of Q2 2026.

  • Alliance Wealth Advisors (Utah) held 813 shares of Amgen worth $294K as of Q2 2026.
  • Alliance Wealth Advisors (Utah) sold 23 Amgen shares in Q2 2026, an estimated $7.87K.
  • Amgen made up 0.06% of Alliance Wealth Advisors (Utah)'s portfolio in Q2 2026, its #191 holding.
  • Alliance Wealth Advisors (Utah) first reported a position in Amgen in Q4 2022 and has held it in 5 quarters since.
  • Alliance Wealth Advisors (Utah)'s Amgen position peaked at $409K in Q4 2022.
  • 1,447 funds tracked by Wall St. Rank held Amgen as of Q2 2026.

Based on Alliance Wealth Advisors (Utah)'s 13F filing for Q2 2026, filed 23 Jul 2026.